What is needed to obtain informed consent and monitor capacity for a successful study involving People with Mild Dementia? Our experience in a multi-centre study [CONFERENCE PAPER]
Jennifer Lim, Rosa Almeida, Vjera Holthoff-Detto, Geke Ludden, Kristina Niedderer
International MinD Conference 2019, 19-12 September 2019; Dresden, Germany
Open Access
Abstract
Strategies on informed consent process and capacity monitoring for mild dementia research are at developing state. We reflected on our experience in the MinD project, and found that the successful collection of informed consent and full participation of PwD required the involvement of familiar healthcare professionals/care workers/staff at the recruitment and data collection stages and this needs to occur in an active support environment. Time is another important factor affecting the success of the study.
Year: 2020
Research without prior consent in paediatric emergency and critical care medicine
Research without prior consent in paediatric emergency and critical care medicine
Symposium: research
Aled Picton, Kerry Woolfall, Mark D. Lyttle, Stuart Hartshorn
Paediatrics and Child Health, 14 December 2019
Abstract
Children and young peoples’ healthcare should be evidence-based yet many treatments are unlicensed or prescribed off-label. Research is needed, but prospective informed consent for many emergency and critical care trials is neither feasible nor ethical – treatments are time critical, and delays for research discussions may cause harm. Research without prior consent (RWPC) is a practical approach which facilitates such research. Trial interventions are administered immediately to eligible patients, and consent for ongoing study involvement is sought after the emergency situation has passed. This has been permitted in the United Kingdom since an amendment to legislation in 2008, and subsequently employed by several trials. Studies demonstrate that most parents are supportive of this approach provided their child’s safety is not compromised, and research discussions are appropriately timed. Practitioners with no experience of RWPC often initially report anxiety about taking this approach, but study experience and training helps change perspectives. Sadly, some children enrolled into such studies will die. Approaching bereaved families for consent requires a bespoke approach, conducted with care and sensitivity. Future research should explore the acceptability of higher risk trials, the viewpoints of children with first-hand experience of this method, and international perspectives.
Adolescent Consent to Vaccination in the Age of Vaccine-Hesitant Parents
Adolescent Consent to Vaccination in the Age of Vaccine-Hesitant Parents
Viewpoint
Tony Yang, Robert S. Olick, Jana Shaw
JAMA Pediatrics, 7 October 2019;173(12) pp 1123-112
Excerpt
As children of vaccine-hesitant parents become adolescents, they develop their individual perspectives on vaccination. One of these adolescents, Ethan Lindenberger, researched vaccines, discussed them with trusted adults, and ultimately got vaccinated.1 His testimony to the Senate Committee on Health, Education, Labor and Pensions made national headlines.1 Many other adolescents are similarly seeking advice on how to get vaccinated. While vaccination against measles and other conditions occurs in early childhood, vaccine-hesitant parents have also refused human papillomavirus vaccination, routinely provided for adolescents beginning at age 11 or 12 years. And they have refused to let their children catch up on any missed early childhood vaccinations. Prior research has shown that adolescents feel generally marginalized in the decision-making process, yet they desire to participate in decisions.2 Their main obstacle to vaccination is that most states require an individual to be 18 years or older to consent to medical procedures.3 We argue for expansion of the rights of adolescents to make their own decisions to be vaccinated against serious and potentially life-threatening diseases without requiring parental consent and involvement…
Consent in children’s intensive care: the voices of the parents of critically ill children and those caring for them
Consent in children’s intensive care: the voices of the parents of critically ill children and those caring for them
Original research
Phoebe Aubugeau-Williams, Joe Brierley
Journal of Medical Ethics, 27 November 2019
Abstract
Despite its invasive nature, specific consent for general anaesthesia is rarely sought—rather consent processes for associated procedures include explanation of risk/benefits. In adult intensive care, because no one can consent to treatments provided to incapacitated adults, standardised consent processes have not developed. In paediatric intensive care, despite the ready availability of those who can provide consent, no tradition of seeking it exists, arguably due to the specialty’s evolution from anaesthesia and adult intensive care. With the current Montgomery-related focus on consent, this seems untenable. We undertook a qualitative study in a specialist children’s hospital colocated paediatric/neonatal intensive care (same medical team) in which parental acceptance of admission and entailed procedures is considered implied by virtue of that admission. Semistructured interviews were carried out with both staff and parents to investigate their views about consent, the current system and a proposed blanket consent system, in which parents actively consent at admission to routine procedures. Divergent views emerged: staff were worried that requiring consent at admission might prove a further emotional burden, whereas parents found providing consent a way of coping, feeling empowered and maintaining control. Inconsistencies were found in the way consent is obtained for your routine procedures. Practice does seem inconsistent with contemporary consent standards for medical intervention. Our findings support the introduction of a blanket consent system at admission together with ongoing bedside dialogue to ensure continuing consent. Both parents and staff expressed concern about avoiding possible harmful delays to children due to parental emotional overload and language difficulties.
National Electronic Health Record Systems and Consent to Processing of Health Data in the European Union and Australia
National Electronic Health Record Systems and Consent to Processing of Health Data in the European Union and Australia
Danuta Mendelson
Legal Tech and the New Sharing Economy, 13 December 2019; pp 83-99
Abstract
This study focuses on the single most important regulatory aspect of data processing, namely consent to data processing. It compares approaches to consent under the General Data Protection Regulation (EU 2016/679) of the European Parliament and of the Council on the protection of natural persons with regard to the processing of personal data (and on the free movement of such) (GDPR) in the context of European Union (EU) national electronic health record (NEHR) schemes (also referred to as “national digital health networks”) with the approach of the Australian national health record scheme called My Health Record (MHR). The GDPR, subject to derogation in limited circumstances, is binding on all 27 EU member countries. Under Articles 168 (2) and (7) of the Treaty on the Functioning of the European Union (2007), while the EU has a duty to “encourage cooperation between the Member States…to improve the complementarity of their health services in cross-border areas,” the European Union Member States retain the power to manage their own health services. However, in doing so, subject to narrow derogations, the management of their NEHR systems must conform to the GDPR. The GDPR governs the processing of data in any form including data contained in national electronic health systems (European Commission Recommendation on a European Electronic Health Record exchange format (C(2019)800) of 6 February 2019… Given that, unlike the Australian MHR scheme, national electronic medical/health records systems of EU Member States are at different stages of development, and that derogations enable a measure of variance in compliance, individual European systems will not be discussed. Australia is a non-EU jurisdiction, and does not have the European Commission’s certificate of adequate level of data protection (GDPR Article 45 empowers the European Commission to determine whether a country outside the EU offers an adequate level of data protection, whether by its domestic legislation or of the international commitments it has entered into. For further discussion, see below). One of the reasons for the absence of certification might be the effectively non-consensual nature of the My Health Record system that administers, collects, stores, and provides access to health and clinical data of Australians.
Too Dense and Too Detailed: Evaluation of the Health Literacy Attributes of an Informed Consent Document
Too Dense and Too Detailed: Evaluation of the Health Literacy Attributes of an Informed Consent Document
Vanessa W. Simonds, Dedra Buchwald
Journal of Racial and Ethnic Health Disparities, 10 December 2019
Abstract
The US government recently updated the Common Rule, a set of federal regulations to ensure the ethical conduct of human subjects research. The new regulations require that consent documents provide information that is clear and concise enough to enable truly informed consent. This study explores potential American Indian research participants’ understanding and perceptions of an example consent document, focusing on possible improvements to better serve the requirements of the revised Common Rule. Participants completed a survey that collected demographic data and measured health literacy, numeracy, and comprehension of the example document. Next, they participated in focus groups to answer open-ended questions regarding their views on the example document. We calculated mean scores and frequencies of response to analyze quantitative survey data and performed a qualitative thematic analysis of focus group transcripts. Results demonstrated that American Indian participants with relatively strong health literacy skills clearly understood key elements of the consent document, including the purpose of signing it, confidentiality, compensation, and whom to contact for questions. However, they were overwhelmed by details on research procedures and were concerned about the document’s layout. To make consent documents more readily comprehensible, participants recommended the addition of headings, bullets, graphics, and relevant pictures. They also recommended a two-step consent process, comprising a short introduction to the research project followed by a longer explanation of procedures. These results illustrate the potential advantages of community engagement in drafting consent materials. Health researchers would likely benefit from community recommendations like the ones we elicited as they design consent documents adherent to the revised Common Rule.
Articulating ‘free, prior and informed consent’ (FPIC) for engineered gene drives
Articulating ‘free, prior and informed consent’ (FPIC) for engineered gene drives
Research Articles
Dalton R. George, Todd Kuiken and Jason A. Delborne
Proceedings of the Royal Society B, 11 December 2019; 286 (1917)
Abstract
Recent statements by United Nations bodies point to free, prior and informed consent (FPIC) as a potential requirement in the development of engineered gene drive applications. As a concept developed in the context of protecting Indigenous rights to self-determination in land development scenarios, FPIC would need to be extended to apply to the context of ecological editing. Without an explicit framework of application, FPIC could be interpreted as a narrowly framed process of community consultation focused on the social implications of technology, and award little formal or advisory power in decision-making to Indigenous peoples and local communities. In this paper, we argue for an articulation of FPIC that attends to issues of transparency, iterative community-scale consent, and shared power through co-development among Indigenous peoples, local communities, researchers and technology developers. In realizing a comprehensive FPIC process, researchers and developers have an opportunity to incorporate enhanced participation and social guidance mechanisms into the design, development and implementation of engineered gene drive applications.
Knowledge, attitude, and practices regarding informed consent for research purposes among postgraduate resident doctors
Knowledge, attitude, and practices regarding informed consent for research purposes among postgraduate resident doctors
Original Research
Noopur Vyas, Pradeep Jadhav, Rohit Sane.
National Journal of Physiology Pharmacy and Pharmacology. 2020; 10(1): 54-58
[country of publication: India]
Open Access
Abstract
Background
Informed consent is an ethical and legal requirement for research involving human participants. Postgraduate (PG) residents are budding doctors who are in their interim phase of education and are engaged in thesis/research work, which mandates adequate knowledge of informed consent and regulatory guidelines. There exists paucity of data in literature on the informed consent process with regard to PG residents; therefore, this study was conducted to assess the knowledge, attitude, and practices (KAP) of informed consent among PG residents.
Aims and Objectives
The aim of the study was to assess the level of knowledge and attitude about the informed consent process and assess practices adopted by PG residents for research purposes.
Materials and Methods
It was a cross-sectional, observational and questionnaire-based study conducted from January 2018 to March 2018 at a tertiary care teaching hospital, Navi Mumbai. The study included PG residents of either sex pursuing specialty MD/MS courses. A validated KAP questionnaire was used to assess KAP of the informed consent process. Responses from the eligible participants were obtained and analyzed.
Results
A total of 100 PG residents participated; 39% of males and 61% of females. Overall, the knowledge score was high and attitude toward informed consent was average. However, 34% participants felt that witness is not necessary, 20% felt that once the patient participates, they should not be allowed to withdraw and few felt that on voluntary withdrawal, participants are not liable for further standard care and compensation. In practice, few participants failed to explain consent in the local language and neglected to take the signature of an impartial witness.
Conclusions
Overall, the KAP of informed consent among PG residents were adequate. Structured continuing medical education/workshops are necessary to advance informed consent practices.
Jordanians’ Perspectives On Open Consent In Biomedical Research
Jordanians’ Perspectives On Open Consent In Biomedical Research
Original Research
Nasr Alrabadi, Hanin Makhlouf, Omar F Khabour, Karem H Alzoubi
Risk Management and Healthcare Policy, 2 December 2019; 2019(12) pp 265—273
Introduction
The informed consent process is an integral step in biomedical research. However, the emergence of biobanks and the need for open consent (also called “broad” or “blanket” consent) create challenges to this process.
Aims and methodology
A survey was used to examine Jordanians’ perspectives on open consent and reuse of stored samples in future research.
Results
The majority of participants had positive perceptions of informed consent and its importance. In addition, they appreciated the challenges that are associated with multiple uses of their biospecimens. About 55% agreed to provide open consent for reuse of their donated biospecimens. Participants (75–80%) also agreed that issues such as the possibility of sharing samples with international research centers, storage duration, and use of biospecimens after their death should be clarified as part of open consent. The inconvenience of the re-contact process, trust in the research team, and the importance of biobanks were all associated with participants’ willingness to provide open consent (P<0.05). On the other hand, privacy and confidentiality, doubt about future use of samples, unknown storage period, and the possibility of cross-border sample sharing were significantly associated with participants’ reluctance to provide open consent.
Conclusion
The majority of Jordanians accept the idea of open consent. Clarification of issues such as international sample sharing, duration of storage, domains of intended research, confidentiality, and privacy can provide more support for the use of open consent.
Promoting informed consent in a children’s hospital in Tabriz, Iran: a best practice implementation project
Promoting informed consent in a children’s hospital in Tabriz, Iran: a best practice implementation project
Neda Kabiri, Sakineh Hajebrahimi, Gisoo Alizadeh, Solmaz Azimzadeh, Nayyereh Farajzadeh, Amin Talebpour
JBI Database of Systematic Reviews and Implementation Reports, December 2019; 17(12) pp 2570–2577
Abstract
Introduction
Informed consent is a continuous and dynamic process. It is a crucial part of healthcare procedures that becomes more complex in a pediatric clinical practice, where parents must make decisions for their children.
Objectives
The aim of this implementation project was to evaluate the current practice and implement the best practice related to obtaining informed consent in a children’s hospital in Tabriz, Iran.
Methods
A clinical audit was undertaken using the JBI Practical Application of Clinical Evidence System (JBI PACES) tool. Five audit criteria representing the best-practice recommendations for informed consent were used. A baseline audit was conducted, followed by the implementation of multiple strategies. The project was finalized with a follow-up audit to determine change in practice.
Results
The compliance rate of all criteria improved from baseline to follow-up audit. Criteria 1 (obtaining informed consent prior to all nursing procedures) and 5 (provision of information related to the necessity of the treatment) reached 97% compliance in the follow-up cycle. Criterion 4 (provision of information related to the nature and effect of the treatment) achieved 74% compliance. Both criteria 2 and 3 (provision of information related to alternative treatments and consequences of refusing treatment) reached 57% in the follow-up cycle. To improve compliance, meetings were organized with the heads of departments, nurses and residents regarding informed consent. Also, staff were encouraged to report cases where informed consent was not obtained.
Conclusion
The audit results indicated an improvement in obtaining informed consent in the included departments. The interventions that were employed can facilitate the implementation of evidence into clinical practice.